Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
17 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/17/2964897/23024/en/Intercept-Provides-Regulatory-Update-Regarding-sNDA-for-OCALIVA.html
17 Sep 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/intercepts-liver-med-ocaliva-takes-heat-fda-expert-meeting-portending-potential-approval
14 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2946202/23024/en/Company-Statement-on-FDA-Advisory-Committee-Meeting.html
12 Sep 2024
// ENDPTS
https://endpts.com/fda-is-poised-to-pull-ocaliva-as-adcomm-documents-question-post-approval-study-results/
06 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/06/2942227/23024/en/Findings-From-COBALT-Trial-Including-External-Control-Arm-Published-in-The-American-Journal-of-Gastroenterology.html
11 Jun 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-genfit-ipsens-liver-disease-drug-2024-06-10/
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : OCALIVA
Dosage Strength : 5MG
Packaging :
Approval Date : 2016-05-27
Application Number : 207999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : OCALIVA
Dosage Strength : 10MG
Packaging :
Approval Date : 2016-05-27
Application Number : 207999
Regulatory Info : RX
Registration Country : USA
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : OCALIVA
Dosage Strength : 5MG
Approval Date : 2016-05-27
Application Number : 207999
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : OCALIVA
Dosage Strength : 10MG
Approval Date : 2016-05-27
Application Number : 207999
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?